Drawing for INSIDE RX

USPTO serial 87363825

INSIDE RX

Reviewed by CopyMark Law Group

Reg. 5456507Status 702Registered
Filing date
Status date
Registration date
May 1, 2018
Examiner
CHANG, KATHERINE S
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with INSIDE RX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
035Administration of a discount program to allow participants to obtain discounts on the cost of prescription drugs through use of a membership card; providing pricing information to others relating to prescription drugsACTIVEMay 8, 2017
042Providing a website featuring temporary use of non-downloadable software for providing pricing of prescription drugsACTIVEJul 31, 2017
044Providing online information regarding health and the use of prescription drugs to treat health conditionsACTIVEJul 31, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 20, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 20, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 20, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 15, 2024E815TEAS SECTION 8 & 15 RECEIVED
May 1, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 4, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 4, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 1, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 13, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 24, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 5, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jan 5, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 4, 2018ALIEASSIGNED TO LIE
Dec 27, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 19, 2017ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 25, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Sep 25, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 25, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 21, 2017AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Sep 20, 2017IUAAUSE AMENDMENT ACCEPTED
Sep 2, 2017AUPCAMENDMENT TO USE PROCESSING COMPLETE
Sep 2, 2017IUAFUSE AMENDMENT FILED
Sep 1, 2017EAAUTEAS AMENDMENT OF USE RECEIVED
Aug 26, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 6, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 6, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 6, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2017DOCKASSIGNED TO EXAMINER
Mar 14, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 11, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance